Conferences
10 December 2021, Online
Cells Webinar | Glucocorticoid-induced Proteins Annexin A1 and GILZ in Inflammation
Glucocorticoids (GCs) are extensively used in clinical practice to treat several inflammatory diseases, representing a successful use of an endogenous molecule for therapeutic purposes. This historical drug has again proven its relevance during the current pandemic, with dexamethasone showing unequivocal benefits in hospitalised COVID-19 patients. However, serious adverse effects and infection risks associated with the long-term use of GC pose clinical challenges. In this context, there is a genuine interest in GC-induced proteins intrinsically involved with the anti-inflammatory functions of GCs without the associated adverse metabolic effects.
The following experts will be present and talk:
- Prof. Dr. Lirlândia P. Sousa, Universidade Federal de Minas Gerais (UFMG), Brazil
- Dr. Stefano Bruscoli, Department of Medicine, University of Perugia, Italy
- Dr. Michelle Sugimoto, Academy of Medical Sciences Newton International Fellow, University College London, Division of Medicine, UK
- Prof. Dr. Mauro Perretti, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London, UK
When? 10 December 2021 at 3:00 pm CET | 9:00am EST | 10:00pm CST Asia
Click here to register now!
Interested in contributing to the topic? You can find the Special Issue(s) linked to this topic and open for submission by clicking here.
